[{"Assets_0_FY_USD":57470000000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.0,"EarningsPerShareDiluted_1_FY_USD":0.1,"EarningsPerShareDiluted_4_FY_USD":-0.91,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1091000000.0,"EarningsPerShareBasic_4_FY_USD":-0.91,"EarningsPerShareBasic_1_FY_USD":0.1,"StockholdersEquityConverted_0_FY_USD":15063000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1091000000.0,"StockholdersEquity_0_FY_USD":13972000000.0,"NetIncomeLossConverted_4_FY_USD":-999000000.0,"NetIncomeLossConverted_1_FY_USD":110000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":748000000.0,"CommonStockSharesConverted_0_FY_shares":1198000000.0,"RevenuesConverted_1_FY_USD":4468000000.0,"RevenuesConverted_4_FY_USD":16887000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200221"}]